1112193-37-9 Usage
General Description
2,3-Dihydro-1H-pyrido[2,3-b][1,4]oxazine is a chemical compound with the molecular formula C7H8N2O. It comes under the category of six-membered heterocyclic compounds with one nitrogen atom and one oxygen atom. This specific compound is not largely studied or reported in literature, which suggests that it may not have significant industrial or pharmaceutical applications currently. However, it might be noteworthy for future research and development in chemistry or biochemistry due its unique structure. The detailed properties like physical, chemical, toxicological or ecological aspects of this chemical compound are largely unknown due to limited research.
Check Digit Verification of cas no
The CAS Registry Mumber 1112193-37-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,1,2,1,9 and 3 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1112193-37:
(9*1)+(8*1)+(7*1)+(6*2)+(5*1)+(4*9)+(3*3)+(2*3)+(1*7)=99
99 % 10 = 9
So 1112193-37-9 is a valid CAS Registry Number.
1112193-37-9Relevant articles and documents
HETEROCYCLIC DERIVATIVES
-
Page/Page column 14, (2011/02/25)
The present invention relates to heterocyclic derivatives, and more particularly, to novel heterocyclic derivatives useful for the preparation of medicaments for treating diseases related to uric acid.
Achieving multi-isoform PI3K inhibition in a series of substituted 3,4-dihydro-2H-benzo[1,4]oxazines
Perry, Benjamin,Alexander, Rikki,Bennett, Gavin,Buckley, George,Ceska, Tom,Crabbe, Tom,Dale, Verity,Gowers, Lewis,Horsley, Helen,James, Lynwen,Jenkins, Kerry,Crepy, Karen,Kulisa, Claire,Lightfoot, Helen,Lock, Chris,Mack, Stephen,Morgan, Trevor,Nicolas, Anne-Lise,Pitt, Will,Sabin, Verity,Wright, Sara
scheme or table, p. 4700 - 4704 (2009/04/08)
The SAR and pharmacokinetic profiles of a series of multi-isoform PI3K inhibitors based on a 3,4-dihydro-2H-benzo[1,4]oxazine scaffold are disclosed.
